DWTX - Dogwood Therapeutics Inc. Year-over-year net earnings per share growth for the last 12 months

Corporate emblem and logo of Dogwood Therapeutics Inc. (DWTX)

Dogwood Therapeutics, Inc. (DWTX) relies on contract manufacturing for its drugs, focusing primarily on scientific research and development. On the GURU.Markets platform, the quarter-over-quarter EPS dynamics illustrate current trends, where the value 98.30 indicates the company's status. The development of fibromyalgia therapy by targeting viral triggers opens up a massive market, while the clinical trial stage confirms the relevance of the drugs for treating chronic ailments.

dwtx.com (DWTX) Year-over-year net earnings per share change for the last twelve months: for the period 10/10/2024 - 11/18/2026

Analytical breakdowns for Dogwood Therapeutics, Inc.

- market value and analyst target forecast:
Fundamental company analysis:dwtx.com, DWTX
Manufactured product of Dogwood Therapeutics, Inc.

This indicator measures the dynamics of net earnings per share, calculated by comparing quarterly total revenues minus all operating expenses. For Dogwood Therapeutics, Inc. (DWTX), which focuses on R&D and delegates production to external contractors, the quarterly EPS trend reflects the efficiency of outsourcing cost management and the potential for alpha generation as profits grow.

Main competitors

Gilead Sciences Inc (GILD) - Year-over-year earnings per share growth for the last twelve months|Cidara - Year-over-year earnings per one share growth for the last 12 months|Year-over-year net earnings per share growth for the last 12 months NVAX|Quarterly EPS earnings growth curevac.com|Year-over-year earnings per share growth for the last twelve months Valneva Corp (VALN)|Year-over-year earnings per share growth for the last twelve months VIR (Vir Biotechnology)|Year-over-year earnings per share growth for the last twelve months TPOXX SIGA|EBS - Year-over-year net earnings per share growth for the last 12 months|AVIR: Year-over-year net earnings per share growth for the last 12 months|IVVD (Invivyd Inc) - Year-over-year earnings per share growth for the last 12 months|ENTA: Quarterly EPS earnings growth|INO (Inovio) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last twelve months HilleVax Corp|Quarterly EPS earnings growth Kalaris Tx|Quarterly EPS earnings growth DYAI|Year-over-year earnings per share growth for the last twelve months NNVC (NanoViricides)|Quarterly EPS earnings growth TLPH (Talphera Corporation)|Year-over-year net earnings per share change for the last twelve months Cocrystal (COCP)|TRAW - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months Qualigen Corp|ALVR (AlloVir Bio) - Year-over-year net earnings per share growth for the last 12 months|Year-over-year net earnings per share growth for the last 12 months VBI Vaccines, Inc.|VIRI (virios.com) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months VXRT (Vaxart, Inc.)